In a significant move within the pharmaceutical industry, Akeso Inc. has secured $250 million to fuel the global expansion and development of its cutting-edge drug pipeline. This funding round was led by prominent investors, highlighting the growing confidence in Akeso’s ability to innovate and deliver impactful healthcare solutions. As the company sets its sights on broadening its market reach, this financing is poised to accelerate the introduction of its novel therapies in the global market.
Support authors and subscribe to content
This is premium stuff. Subscribe to read the entire article.